Daily Record, The (Baltimore) - Germantown-based Advancis Pharmaceutical Corp.’s losses mount
As a result of reduced revenue and high expenses associated with the launch of its Keflex 750 mg capsules, Advancis Pharmaceutical Corp., of Germantown, reported a third-quarter net loss of $9.9 million, or 36 cents per diluted share, on revenue of $2.4 million, versus a net loss of $5.9 million, or 20 cents per diluted share, on revenue of $7.4 million for the year-ago period.
Most Popular
Business Plan Sample
Public Speaking: 7 Secrets Of Great Public Speakers
13 Job Interview Mistakes To Avoid
10 Jobs That Pay $30 An Hour
3 Questions No Job Seeker Ever Wants To Be Asked?
Copyright 2006 Dolan Media Newswires
Provided by ProQuest Information and Learning Company. All rights Reserved.
